Dr. Martens First Half 2025 Earnings: UK£0.022 loss per share (vs UK£0.019 profit in 1H 2024)

Dr. Martens (LON:DOCS) First Half 2025 Results

Key Financial Results

• Revenue: UK£324.6m (down 18% from 1H 2024).
• Net loss: UK£20.8m (down by 210% from UK£19.0m profit in 1H 2024).
• UK£0.022 loss per share (down from UK£0.019 profit in 1H 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Dr. Martens Earnings Insights

Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Luxury industry in Europe.

Performance of the market in the United Kingdom.

The company's shares are up 17% from a week ago.

Risk Analysis

You should learn about the 4 warning signs we've spotted with Dr. Martens (including 1 which is potentially serious).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.